25 XP   0   0   10

Gossamer Bio Inc
Buy, Hold or Sell?

Let's analyse Gossamer Bio Inc together

PenkeI guess you are interested in Gossamer Bio Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Gossamer Bio Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Gossamer Bio Inc

I send you an email if I find something interesting about Gossamer Bio Inc.

Quick analysis of Gossamer Bio Inc (30 sec.)










What can you expect buying and holding a share of Gossamer Bio Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
3.8%

What is your share worth?

Current worth
$0.28
Expected worth in 1 year
$0.50
How sure are you?
26.9%

+ What do you gain per year?

Total Gains per Share
$0.23
Return On Investment
19.2%

For what price can you sell your share?

Current Price per Share
$1.18
Expected price per share
$1.03 - $1.85
How sure are you?
50%

1. Valuation of Gossamer Bio Inc (5 min.)




Live pricePrice per Share (EOD)

$1.18

Intrinsic Value Per Share

$-4.14 - $-4.64

Total Value Per Share

$-3.86 - $-4.36

2. Growth of Gossamer Bio Inc (5 min.)




Is Gossamer Bio Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$62.7m$20.5m-$1.4m-7.9%

How much money is Gossamer Bio Inc making?

Current yearPrevious yearGrowGrow %
Making money-$46.1m-$60m$13.9m30.1%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Gossamer Bio Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#452 / 1031

Most Revenue
#979 / 1031

Most Profit
#912 / 1031

Most Efficient
#435 / 1031

What can you expect buying and holding a share of Gossamer Bio Inc? (5 min.)

Welcome investor! Gossamer Bio Inc's management wants to use your money to grow the business. In return you get a share of Gossamer Bio Inc.

What can you expect buying and holding a share of Gossamer Bio Inc?

First you should know what it really means to hold a share of Gossamer Bio Inc. And how you can make/lose money.

Speculation

The Price per Share of Gossamer Bio Inc is $1.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gossamer Bio Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gossamer Bio Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.28. Based on the TTM, the Book Value Change Per Share is $0.06 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.12 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gossamer Bio Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.21-18.1%-0.20-16.9%-0.25-21.5%-0.24-20.0%-0.21-17.9%
Usd Book Value Change Per Share-0.19-15.7%0.064.8%-0.12-10.3%0.043.4%0.010.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.19-15.7%0.064.8%-0.12-10.3%0.043.4%0.010.9%
Usd Price Per Share0.91-1.05-7.80-9.91-7.62-
Price to Earnings Ratio-1.07--1.32--7.60--10.94--8.42-
Price-to-Total Gains Ratio-4.92--4.69--8.97--27.59--27.59-
Price to Book Ratio3.28--2.31-9.68-7.00-5.38-
Price-to-Total Gains Ratio-4.92--4.69--8.97--27.59--27.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.18
Number of shares847
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.060.04
Usd Total Gains Per Share0.060.04
Gains per Quarter (847 shares)47.9334.39
Gains per Year (847 shares)191.70137.58
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
111901820137128
233813741275266
345715661412404
457617581549542
579529501687680
68114211422824818
710133213342961956
81115231526210981094
91217131718212361232
101419031910313731370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.025.01.00.0%0.025.01.00.0%
Book Value Change Per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%7.018.01.026.9%7.018.01.026.9%
Dividend per Share1.00.03.025.0%1.00.011.08.3%1.00.019.05.0%1.00.025.03.8%1.00.025.03.8%
Total Gains per Share1.03.00.025.0%2.010.00.016.7%5.015.00.025.0%7.018.01.026.9%7.018.01.026.9%

Fundamentals of Gossamer Bio Inc

About Gossamer Bio Inc

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-03-20 19:30:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Gossamer Bio Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Gossamer Bio Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Gossamer Bio Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Gossamer Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--159.2%+159.2%
TTM--202.3%+202.3%
YOY--263.0%+263.0%
5Y--452.4%+452.4%
10Y--589.0%+589.0%
1.1.2. Return on Assets

Shows how efficient Gossamer Bio Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gossamer Bio Inc to the Biotechnology industry mean.
  • -15.4% Return on Assets means that Gossamer Bio Inc generated $-0.15 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Gossamer Bio Inc:

  • The MRQ is -15.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.4%TTM-18.7%+3.3%
TTM-18.7%YOY-21.3%+2.6%
TTM-18.7%5Y-15.2%-3.6%
5Y-15.2%10Y-72.9%+57.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.4%-12.5%-2.9%
TTM-18.7%-12.2%-6.5%
YOY-21.3%-11.2%-10.1%
5Y-15.2%-13.3%-1.9%
10Y-72.9%-14.6%-58.3%
1.1.3. Return on Equity

Shows how efficient Gossamer Bio Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gossamer Bio Inc to the Biotechnology industry mean.
  • -76.7% Return on Equity means Gossamer Bio Inc generated $-0.77 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Gossamer Bio Inc:

  • The MRQ is -76.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -28.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-76.7%TTM-28.7%-48.0%
TTM-28.7%YOY-78.6%+49.8%
TTM-28.7%5Y-32.4%+3.6%
5Y-32.4%10Y-25.7%-6.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-76.7%-16.0%-60.7%
TTM-28.7%-15.8%-12.9%
YOY-78.6%-13.9%-64.7%
5Y-32.4%-18.2%-14.2%
10Y-25.7%-19.1%-6.6%

1.2. Operating Efficiency of Gossamer Bio Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Gossamer Bio Inc is operating .

  • Measures how much profit Gossamer Bio Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gossamer Bio Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Gossamer Bio Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.5%+299.5%
TTM--208.5%+208.5%
YOY--280.2%+280.2%
5Y--459.9%+459.9%
10Y--596.9%+596.9%
1.2.2. Operating Ratio

Measures how efficient Gossamer Bio Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Gossamer Bio Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.817-2.817
TTM-3.181-3.181
YOY-3.609-3.609
5Y-5.554-5.554
10Y-7.396-7.396

1.3. Liquidity of Gossamer Bio Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Gossamer Bio Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 5.94 means the company has $5.94 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Gossamer Bio Inc:

  • The MRQ is 5.941. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.879. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.941TTM5.879+0.061
TTM5.879YOY6.152-0.273
TTM5.8795Y11.204-5.325
5Y11.20410Y10.386+0.818
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9413.987+1.954
TTM5.8794.440+1.439
YOY6.1525.569+0.583
5Y11.2046.158+5.046
10Y10.3866.492+3.894
1.3.2. Quick Ratio

Measures if Gossamer Bio Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gossamer Bio Inc to the Biotechnology industry mean.
  • A Quick Ratio of 10.87 means the company can pay off $10.87 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Gossamer Bio Inc:

  • The MRQ is 10.867. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.990. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ10.867TTM9.990+0.877
TTM9.990YOY9.088+0.902
TTM9.9905Y15.766-5.775
5Y15.76610Y14.004+1.761
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ10.8673.653+7.214
TTM9.9904.158+5.832
YOY9.0885.515+3.573
5Y15.7666.012+9.754
10Y14.0046.206+7.798

1.4. Solvency of Gossamer Bio Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Gossamer Bio Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gossamer Bio Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.80 means that Gossamer Bio Inc assets are financed with 79.9% credit (debt) and the remaining percentage (100% - 79.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Gossamer Bio Inc:

  • The MRQ is 0.799. The company is just able to pay all its debts by selling its assets.
  • The TTM is 0.993. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.799TTM0.993-0.194
TTM0.993YOY0.937+0.057
TTM0.9935Y0.658+0.335
5Y0.65810Y1.325-0.666
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7990.336+0.463
TTM0.9930.330+0.663
YOY0.9370.267+0.670
5Y0.6580.367+0.291
10Y1.3250.378+0.947
1.4.2. Debt to Equity Ratio

Measures if Gossamer Bio Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gossamer Bio Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 396.9% means that company has $3.97 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Gossamer Bio Inc:

  • The MRQ is 3.969. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.574. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ3.969TTM1.574+2.396
TTM1.574YOY3.378-1.804
TTM1.5745Y1.325+0.249
5Y1.32510Y1.021+0.303
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.9690.376+3.593
TTM1.5740.398+1.176
YOY3.3780.334+3.044
5Y1.3250.431+0.894
10Y1.0210.476+0.545

2. Market Valuation of Gossamer Bio Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Gossamer Bio Inc generates.

  • Above 15 is considered overpriced but always compare Gossamer Bio Inc to the Biotechnology industry mean.
  • A PE ratio of -1.07 means the investor is paying $-1.07 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Gossamer Bio Inc:

  • The EOD is -1.382. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.069. Based on the earnings, the company is expensive. -2
  • The TTM is -1.320. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.382MRQ-1.069-0.313
MRQ-1.069TTM-1.320+0.251
TTM-1.320YOY-7.602+6.281
TTM-1.3205Y-10.941+9.620
5Y-10.94110Y-8.416-2.525
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.382-2.697+1.315
MRQ-1.069-2.422+1.353
TTM-1.320-2.709+1.389
YOY-7.602-4.116-3.486
5Y-10.941-6.257-4.684
10Y-8.416-6.478-1.938
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Gossamer Bio Inc:

  • The EOD is -1.991. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.540. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.503. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.991MRQ-1.540-0.451
MRQ-1.540TTM-1.503-0.038
TTM-1.503YOY-9.890+8.388
TTM-1.5035Y-13.309+11.806
5Y-13.30910Y-10.238-3.071
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.991-3.344+1.353
MRQ-1.540-2.939+1.399
TTM-1.503-3.486+1.983
YOY-9.890-5.592-4.298
5Y-13.309-8.464-4.845
10Y-10.238-8.872-1.366
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Gossamer Bio Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.28 means the investor is paying $3.28 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Gossamer Bio Inc:

  • The EOD is 4.241. Based on the equity, the company is fair priced.
  • The MRQ is 3.281. Based on the equity, the company is fair priced.
  • The TTM is -2.305. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD4.241MRQ3.281+0.960
MRQ3.281TTM-2.305+5.587
TTM-2.305YOY9.678-11.983
TTM-2.3055Y6.998-9.304
5Y6.99810Y5.383+1.615
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD4.2412.198+2.043
MRQ3.2812.042+1.239
TTM-2.3052.121-4.426
YOY9.6782.907+6.771
5Y6.9983.682+3.316
10Y5.3834.114+1.269
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Gossamer Bio Inc.

3.1. Institutions holding Gossamer Bio Inc

Institutions are holding 93.302% of the shares of Gossamer Bio Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31NEA Management Company, LLC7.02090.9632158380091100670.6998
2023-12-31FMR Inc5.43660.000912263918116254971820.9766
2023-12-31Artal Group S A5.34570.365812058968565914988.4267
2023-12-31Vanguard Group Inc5.1580.0002116356343673063.2596
2023-12-31EcoR1 Capital, LLC4.07630.2179919540400
2023-09-30Octagon Capital Advisors LP3.62971.047681878834229814106.8656
2023-12-31ARCH VENTURE CORP3.57124.4958805591600
2023-12-31Junked Platinum Investment Management Ltd3.08270.25776954110159633229.7947
2023-09-30Alyeska Investment Group, L.P.3.0160.0385680350068035000
2023-12-31Eversept Partners, LLC2.85160.51576432715200485845.2783
2023-09-30Citadel Advisors Llc2.73430.001161681434741674332.4064
2023-12-31Farallon Capital Management, L.L.C.2.71750.0278613027200
2023-12-31SILVERARC CAPITAL MANAGEMENT, LLC2.71751.665613026800
2023-12-31Samsara BioCapital, LLC2.71750.8702613026800
2023-12-31Palo Alto Investors, LLC2.64160.58845958888-571400-8.75
2023-12-31Morgan Stanley - Brokerage Accounts2.46870.0005556887251775011322.9138
2023-12-31Goldman Sachs Group Inc2.41710.000554525023788000227.5756
2023-12-31Madison Avenue Partners, LP2.24060.65125054472-1075796-17.5489
2023-12-31Hillhouse Capital Advisors, Ltd.2.2050.0915497404100
2023-12-31Millennium Management LLC1.87280.00174224610-2826750-40.088
Total 67.921311.8012153218393+41629752+27.2%

3.2. Funds holding Gossamer Bio Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Fidelity Select Biotechnology5.39140.22151216207600
2024-02-29Vanguard Total Stock Mkt Idx Inv3.47120.0007783037600
2023-12-31Federated Hermes Kaufmann Small Cap Grow1.69850.0781383142000
2023-12-31Federated Hermes Kaufmann Small Cap A1.69850.0781383142000
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.27090.004286698500
2024-02-29Xtrackers S&P 500 Swap ETF 1C0.92980.0327209744800
2024-01-31Fidelity Extended Market Index0.49210.0026111009300
2024-02-29Schwab US Small-Cap ETF™0.41190.007792925700
2023-12-31Victory Science & Technology0.35590.06588027958027950
2024-02-29Vanguard Health Care ETF0.29010.004465446133280.5111
2023-09-30BlackRock Extended Mkt Composite0.21890.0029493756331479204.2674
2023-12-31BlackRock Extended Equity Market K0.1910.0029430761-868-0.2011
2024-01-31Fidelity Total Market Index0.18440.000441606700
2024-01-31Fidelity Series Total Market Index0.12670.0004285743-4446-1.5321
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.08740.002919725000
2024-02-29iShares Micro-Cap ETF0.080.027918054100
2023-12-31NT Ext Equity Mkt Idx Fd - L0.07780.002717541300
2023-12-31Northern Trust Extended Eq Market Idx0.07780.002717541300
2024-02-29Schwab US Broad Market ETF™0.07250.000816363300
2023-12-31Victory RS Science and Technology A0.07230.08471630301630300
Total 17.19910.623938797938+1295318+3.3%

3.3. Insider Transactions

Insiders are holding 2.283% of the shares of Gossamer Bio Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-03-18Richard ArandaSELL40181.33
2023-11-13Bryan GiraudoBUY2000000.56
2023-06-22Richard ArandaSELL18141.29
2023-04-04Bryan GiraudoBUY550001.02
2023-03-22Faheem HasnainBUY4405001.14
2023-03-20Bryan GiraudoBUY500000.97
2023-03-20Faheem HasnainBUY1686831.03
2023-03-20Waage ChristianBUY185001.2

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Gossamer Bio Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1860.056-430%-0.121-35%0.041-558%0.011-1833%
Book Value Per Share--0.2780.084+230%0.091+206%0.698-60%0.574-52%
Current Ratio--5.9415.879+1%6.152-3%11.204-47%10.386-43%
Debt To Asset Ratio--0.7990.993-20%0.937-15%0.658+21%1.325-40%
Debt To Equity Ratio--3.9691.574+152%3.378+18%1.325+200%1.021+289%
Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Eps---0.213-0.199-7%-0.254+19%-0.236+11%-0.211-1%
Free Cash Flow Per Share---0.148-0.176+19%-0.208+40%-0.197+33%-0.165+11%
Free Cash Flow To Equity Per Share---0.1610.034-570%-0.078-52%0.012-1426%0.048-433%
Gross Profit Margin--1.0151.004+1%1.000+1%1.001+1%0.962+5%
Intrinsic Value_10Y_max---4.643--------
Intrinsic Value_10Y_min---4.143--------
Intrinsic Value_1Y_max---0.747--------
Intrinsic Value_1Y_min---0.734--------
Intrinsic Value_3Y_max---2.030--------
Intrinsic Value_3Y_min---1.943--------
Intrinsic Value_5Y_max---3.054--------
Intrinsic Value_5Y_min---2.854--------
Market Cap266186760.000+23%205956366.000237199473.000-13%1759539600.000-88%2235021339.600-91%1719247184.308-88%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio4.241+23%3.281-2.305+170%9.678-66%6.998-53%5.383-39%
Pe Ratio-1.382-29%-1.069-1.320+23%-7.602+611%-10.941+923%-8.416+687%
Price Per Share1.180+23%0.9131.052-13%7.800-88%9.908-91%7.621-88%
Price To Free Cash Flow Ratio-1.991-29%-1.540-1.503-2%-9.890+542%-13.309+764%-10.238+565%
Price To Total Gains Ratio-6.361-29%-4.922-4.689-5%-8.972+82%-27.592+461%-27.592+461%
Quick Ratio--10.8679.990+9%9.088+20%15.766-31%14.004-22%
Return On Assets---0.154-0.187+21%-0.213+38%-0.152-2%-0.729+372%
Return On Equity---0.767-0.287-63%-0.786+2%-0.324-58%-0.257-67%
Total Gains Per Share---0.1860.057-428%-0.121-35%0.041-557%0.011-1823%
Usd Book Value--62769000.00019032500.000+230%20531500.000+206%157495600.000-60%129443115.385-52%
Usd Book Value Change Per Share---0.1860.056-430%-0.121-35%0.041-558%0.011-1833%
Usd Book Value Per Share--0.2780.084+230%0.091+206%0.698-60%0.574-52%
Usd Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Usd Eps---0.213-0.199-7%-0.254+19%-0.236+11%-0.211-1%
Usd Free Cash Flow---33424000.000-39804500.000+19%-46876750.000+40%-44493950.000+33%-37224423.077+11%
Usd Free Cash Flow Per Share---0.148-0.176+19%-0.208+40%-0.197+33%-0.165+11%
Usd Free Cash Flow To Equity Per Share---0.1610.034-570%-0.078-52%0.012-1426%0.048-433%
Usd Market Cap266186760.000+23%205956366.000237199473.000-13%1759539600.000-88%2235021339.600-91%1719247184.308-88%
Usd Price Per Share1.180+23%0.9131.052-13%7.800-88%9.908-91%7.621-88%
Usd Profit---48148000.000-46135000.000-4%-60044500.000+25%-54119450.000+12%-47531076.923-1%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.1860.057-428%-0.121-35%0.041-557%0.011-1823%
 EOD+5 -3MRQTTM+13 -19YOY+17 -135Y+10 -2210Y+9 -23

4.2. Fundamental Score

Let's check the fundamental score of Gossamer Bio Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.382
Price to Book Ratio (EOD)Between0-14.241
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than110.867
Current Ratio (MRQ)Greater than15.941
Debt to Asset Ratio (MRQ)Less than10.799
Debt to Equity Ratio (MRQ)Less than13.969
Return on Equity (MRQ)Greater than0.15-0.767
Return on Assets (MRQ)Greater than0.05-0.154
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Gossamer Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.051
Ma 20Greater thanMa 501.364
Ma 50Greater thanMa 1001.135
Ma 100Greater thanMa 2000.994
OpenGreater thanClose1.200
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets311,916
Total Liabilities249,147
Total Stockholder Equity62,769
 As reported
Total Liabilities 249,147
Total Stockholder Equity+ 62,769
Total Assets = 311,916

Assets

Total Assets311,916
Total Current Assets306,519
Long-term Assets5,397
Total Current Assets
Cash And Cash Equivalents 32,109
Short-term Investments 264,316
Other Current Assets 10,094
Total Current Assets  (as reported)306,519
Total Current Assets  (calculated)306,519
+/- 0
Long-term Assets
Property Plant Equipment 4,779
Long-term Assets Other 618
Long-term Assets  (as reported)5,397
Long-term Assets  (calculated)5,397
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities51,598
Long-term Liabilities197,549
Total Stockholder Equity62,769
Total Current Liabilities
Short-term Debt 14,915
Short Long Term Debt 11,613
Accounts payable 5,526
Other Current Liabilities 31,157
Total Current Liabilities  (as reported)51,598
Total Current Liabilities  (calculated)63,211
+/- 11,613
Long-term Liabilities
Long term Debt 197,405
Capital Lease Obligations 3,446
Long-term Liabilities  (as reported)197,549
Long-term Liabilities  (calculated)200,851
+/- 3,302
Total Stockholder Equity
Common Stock23
Retained Earnings -1,212,040
Accumulated Other Comprehensive Income -350
Other Stockholders Equity 1,275,136
Total Stockholder Equity (as reported)62,769
Total Stockholder Equity (calculated)62,769
+/-0
Other
Capital Stock23
Cash and Short Term Investments 296,425
Common Stock Shares Outstanding 225,409
Liabilities and Stockholders Equity 311,916
Net Debt 180,355
Net Invested Capital 271,787
Net Working Capital 254,921
Property Plant and Equipment Gross 10,211
Short Long Term Debt Total 212,464



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312016-12-31
> Total Assets 
60
445
54,747
54,747
262,181
239,419
515,949
507,174
469,754
426,604
371,478
625,076
584,178
539,433
482,469
432,510
387,038
343,657
294,679
245,844
323,538
272,450
219,906
181,746
347,925
311,916
311,916347,925181,746219,906272,450323,538245,844294,679343,657387,038432,510482,469539,433584,178625,076371,478426,604469,754507,174515,949239,419262,18154,74754,74744560
   > Total Current Assets 
0
445
52,908
52,908
258,351
231,953
497,788
489,586
452,374
409,317
355,438
608,400
555,378
522,322
465,847
416,987
373,992
331,780
280,774
232,682
312,032
261,880
210,413
173,376
341,490
306,519
306,519341,490173,376210,413261,880312,032232,682280,774331,780373,992416,987465,847522,322555,378608,400355,438409,317452,374489,586497,788231,953258,35152,90852,9084450
       Cash And Cash Equivalents 
60
315
32,146
32,146
141,067
105,219
170,847
148,500
130,708
135,089
111,353
486,062
461,956
486,055
439,659
342,453
213,474
183,403
138,907
94,316
153,477
111,973
65,242
37,004
82,609
32,109
32,10982,60937,00465,242111,973153,47794,316138,907183,403213,474342,453439,659486,055461,956486,062111,353135,089130,708148,500170,847105,219141,06732,14632,14631560
       Short-term Investments 
0
0
20,005
20,005
115,376
123,439
310,374
315,495
315,764
266,740
234,812
114,302
93,422
26,573
13,638
63,466
152,546
141,815
132,716
127,845
150,906
143,705
136,614
125,122
246,279
264,316
264,316246,279125,122136,614143,705150,906127,845132,716141,815152,54663,46613,63826,57393,422114,302234,812266,740315,764315,495310,374123,439115,37620,00520,00500
       Net Receivables 
0
0
0
0
0
0
0
0
0
1,500
1,300
600
500
200
200
100
200
200
200
200
100
0
0
100
0
0
00100001002002002002001002002005006001,3001,500000000000
       Other Current Assets 
0
130
200
200
1,708
3,095
16,567
25,591
5,902
7,488
9,273
8,036
10,828
9,129
11,985
10,502
7,908
6,498
9,087
10,521
7,649
6,202
8,557
11,250
12,602
10,094
10,09412,60211,2508,5576,2027,64910,5219,0876,4987,90810,50211,9859,12910,8288,0369,2737,4885,90225,59116,5673,0951,7082002001300
   > Long-term Assets 
0
0
0
0
3,830
7,466
18,161
17,588
17,380
17,287
16,040
16,676
28,800
17,111
16,622
15,523
13,046
11,877
13,905
13,162
11,506
10,570
9,493
8,370
6,435
5,397
5,3976,4358,3709,49310,57011,50613,16213,90511,87713,04615,52316,62217,11128,80016,67616,04017,28717,38017,58818,1617,4663,8300000
       Property Plant Equipment 
0
0
1,414
1,414
3,007
3,193
16,032
16,221
15,993
15,728
15,406
16,049
17,111
16,084
15,612
14,453
11,932
10,797
12,886
11,908
10,877
9,890
8,750
7,600
5,786
4,779
4,7795,7867,6008,7509,89010,87711,90812,88610,79711,93214,45315,61216,08417,11116,04915,40615,72815,99316,22116,0323,1933,0071,4141,41400
       Other Assets 
0
0
425
425
823
4,273
2,129
1,367
1,387
1,559
634
627
861
1,027
1,010
1,070
1,114
1,080
1,019
1,254
629
680
0
770
0
0
0077006806291,2541,0191,0801,1141,0701,0101,0278616276341,5591,3871,3672,1294,27382342542500
> Total Liabilities 
183
7,307
6,710
6,710
15,592
359,488
35,689
65,730
70,881
74,119
65,015
204,752
1,097,104
218,749
210,385
211,817
217,229
222,194
264,520
262,305
267,187
260,373
248,362
244,546
243,308
249,147
249,147243,308244,546248,362260,373267,187262,305264,520222,194217,229211,817210,385218,7491,097,104204,75265,01574,11970,88165,73035,689359,48815,5926,7106,7107,307183
   > Total Current Liabilities 
143
1,266
6,245
6,245
14,939
20,403
25,152
27,511
33,169
36,923
28,362
27,544
32,607
38,650
29,444
29,982
35,896
39,859
34,568
44,408
52,645
49,230
40,571
40,140
42,316
51,598
51,59842,31640,14040,57149,23052,64544,40834,56839,85935,89629,98229,44438,65032,60727,54428,36236,92333,16927,51125,15220,40314,9396,2456,2451,266143
       Short-term Debt 
0
0
0
0
0
0
2,170
2,229
2,291
2,354
2,418
3,245
3,548
3,633
3,518
3,403
3,030
2,902
2,761
14,446
14,520
14,596
14,673
14,753
14,833
14,915
14,91514,83314,75314,67314,59614,52014,4462,7612,9023,0303,4033,5183,6333,5483,2452,4182,3542,2912,2292,170000000
       Short Long Term Debt 
0
0
0
0
0
0
2,170
0
0
0
0
0
0
0
0
0
0
0
0
11,613
11,613
11,613
11,613
11,613
11,613
11,613
11,61311,61311,61311,61311,61311,61311,6130000000000002,170000000
       Accounts payable 
40
97
880
880
3,622
2,182
4,548
3,030
2,555
956
2,602
222
865
7,508
1,073
895
1,185
3,244
592
3,908
363
1,459
2,731
2,205
1,251
5,526
5,5261,2512,2052,7311,4593633,9085923,2441,1858951,0737,5088652222,6029562,5553,0304,5482,1823,6228808809740
       Other Current Liabilities 
103
1,169
0
0
11,317
18,221
18,434
22,252
28,323
33,613
23,342
24,077
28,194
27,509
24,853
25,684
31,681
36,615
31,215
26,054
37,762
33,175
23,167
26,322
29,452
31,157
31,15729,45226,32223,16733,17537,76226,05431,21536,61531,68125,68424,85327,50928,19424,07723,34233,61328,32322,25218,43418,22111,317001,169103
   > Long-term Liabilities 
0
6,041
0
0
653
339,085
10,537
38,219
37,712
37,196
36,653
177,208
179,470
180,099
180,941
181,835
181,333
182,335
229,952
217,897
214,542
211,143
207,791
204,406
200,992
197,549
197,549200,992204,406207,791211,143214,542217,897229,952182,335181,333181,835180,941180,099179,470177,20836,65337,19637,71238,21910,537339,085653006,0410
       Long term Debt Total 
0
0
0
0
0
0
0
28,281
28,370
28,459
28,548
28,637
28,665
0
28,823
28,905
28,991
0
29,167
0
0
0
0
0
0
0
000000029,167028,99128,90528,823028,66528,63728,54828,45928,37028,2810000000
       Other Liabilities 
0
1
465
465
653
718
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000071865346546510
       Deferred Long Term Liability 
0
0
0
0
0
2,100
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000002,10000000
> Total Stockholder Equity
0
-6,862
-6,862
-60,778
246,589
-120,069
480,260
-230,972
398,873
352,485
306,463
420,324
-512,926
320,684
272,084
220,693
169,809
121,463
30,159
-16,461
56,351
-1,032,223
-1,081,388
-62,800
104,617
62,769
62,769104,617-62,800-1,081,388-1,032,22356,351-16,46130,159121,463169,809220,693272,084320,684-512,926420,324306,463352,485398,873-230,972480,260-120,069246,589-60,778-6,862-6,8620
   Common Stock
0
0
1
1
5
2
7
7
7
7
7
8
8
8
8
8
8
8
8
8
10
10
10
10
23
23
23231010101088888888877777251100
   Retained Earnings Total Equity00-1,123,884-1,081,388-1,032,223-976,459-917,096-860,630-811,534-755,250-695,003-635,171-577,530-512,926-455,114-388,244-334,170-279,472-230,972-186,474000000
   Accumulated Other Comprehensive Income 
0
0
0
0
235
-61
79
496
328
258
-505
567
342
599
158
274
137
45
-340
-514
-585
-574
-436
-481
-618
-350
-350-618-481-436-574-585-514-34045137274158599342567-50525832849679-612350000
   Capital Surplus 
0
0
0
0
0
33,853
666,648
671,913
678,010
686,390
695,205
874,863
884,677
897,607
907,089
915,414
924,914
932,944
891,121
901,141
1,033,385
1,044,864
1,053,358
1,061,555
0
0
001,061,5551,053,3581,044,8641,033,385901,141891,121932,944924,914915,414907,089897,607884,677874,863695,205686,390678,010671,913666,64833,85300000
   Treasury Stock00000000000000000000000000
   Other Stockholders Equity 
0
32
3
3
361,418
33,853
150,699
-507,677
208,256
686,390
695,205
874,863
884,677
897,607
907,089
915,414
924,914
932,944
891,121
901,141
1,033,385
564
426
1,061,555
1,269,104
1,275,136
1,275,1361,269,1041,061,5554265641,033,385901,141891,121932,944924,914915,414907,089897,607884,677874,863695,205686,390208,256-507,677150,69933,853361,41833320



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-4,385
Gross Profit-4,385-4,385
 
Operating Income (+$)
Gross Profit-4,385
Operating Expense-169,374
Operating Income-173,759-173,759
 
Operating Expense (+$)
Research Development133,697
Selling General Administrative38,455
Selling And Marketing Expenses2,778
Operating Expense169,374174,930
 
Net Interest Income (+$)
Interest Income2,281
Interest Expense-13,511
Other Finance Cost-218
Net Interest Income-11,448
 
Pretax Income (+$)
Operating Income-173,759
Net Interest Income-11,448
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-179,817-167,701
EBIT - interestExpense = -187,270
-179,817
-166,306
Interest Expense13,511
Earnings Before Interest and Taxes (EBIT)-173,759-166,306
Earnings Before Interest and Taxes (EBITDA)-169,374
 
After tax Income (+$)
Income Before Tax-179,817
Tax Provision-0
Net Income From Continuing Ops-187,433-179,817
Net Income-179,817
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses173,759
Total Other Income/Expenses Net-6,05811,448
 

Technical Analysis of Gossamer Bio Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gossamer Bio Inc. The general trend of Gossamer Bio Inc is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gossamer Bio Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Gossamer Bio Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.27 < 1.6 < 1.85.

The bearish price targets are: 1.13 > 1.13 > 1.03.

Tweet this
Gossamer Bio Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Gossamer Bio Inc. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Gossamer Bio Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Gossamer Bio Inc. The current macd is 0.01422125.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Gossamer Bio Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Gossamer Bio Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Gossamer Bio Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Gossamer Bio Inc Daily Moving Average Convergence/Divergence (MACD) ChartGossamer Bio Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Gossamer Bio Inc. The current adx is 31.41.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Gossamer Bio Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Gossamer Bio Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Gossamer Bio Inc. The current sar is 1.41128789.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Gossamer Bio Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Gossamer Bio Inc. The current rsi is 42.05. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Gossamer Bio Inc Daily Relative Strength Index (RSI) ChartGossamer Bio Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Gossamer Bio Inc. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Gossamer Bio Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Gossamer Bio Inc Daily Stochastic Oscillator ChartGossamer Bio Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Gossamer Bio Inc. The current cci is -194.20172593.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Gossamer Bio Inc Daily Commodity Channel Index (CCI) ChartGossamer Bio Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Gossamer Bio Inc. The current cmo is -33.22940307.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Gossamer Bio Inc Daily Chande Momentum Oscillator (CMO) ChartGossamer Bio Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Gossamer Bio Inc. The current willr is -84.44444444.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Gossamer Bio Inc Daily Williams %R ChartGossamer Bio Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Gossamer Bio Inc.

Gossamer Bio Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Gossamer Bio Inc. The current atr is 0.10780303.

Gossamer Bio Inc Daily Average True Range (ATR) ChartGossamer Bio Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Gossamer Bio Inc. The current obv is -116,037,145.

Gossamer Bio Inc Daily On-Balance Volume (OBV) ChartGossamer Bio Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Gossamer Bio Inc. The current mfi is 35.29.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Gossamer Bio Inc Daily Money Flow Index (MFI) ChartGossamer Bio Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Gossamer Bio Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-17STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-21RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-04BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-02MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-02-23STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-26MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-28STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-21WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Gossamer Bio Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Gossamer Bio Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.051
Ma 20Greater thanMa 501.364
Ma 50Greater thanMa 1001.135
Ma 100Greater thanMa 2000.994
OpenGreater thanClose1.200
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Gossamer Bio Inc with someone you think should read this too:
  • Are you bullish or bearish on Gossamer Bio Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gossamer Bio Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Gossamer Bio Inc

I send you an email if I find something interesting about Gossamer Bio Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Gossamer Bio Inc.

Receive notifications about Gossamer Bio Inc in your mailbox!